Pages not connected to items
This page lists pages with no connected data item (in namespaces that support connected items).
Showing below up to 50 results in range #6,951 to #7,000.
- long-chain fatty acid biosynthetic process (Q22043)
- long-chain fatty acid import across plasma membrane (Q22042)
- wide pore channel activity (Q22041)
- porin activity (Q22040)
- long-chain fatty acid transporting porin activity (Q22039)
- peroxisomal transport (Q22038)
- peroxisomal membrane transport (Q22037)
- long-chain fatty acid import into peroxisome (Q22036)
- long-chain fatty acid transporter activity (Q22035)
- long-chain fatty acid transport (Q22034)
- long-chain fatty acid import into cell (Q22033)
- long chain fatty acid (Q22032)
- list of unsaturated fatty acids (Q22031)
- unsaturated fatty acid metabolic process (Q22030)
- unsaturated fatty acid biosynthetic process (Q22029)
- unsaturated fatty acids (Q22028)
- omega-3 fatty acid (Q22027)
- lumisterol (Q22026)
- paricalcitol (Q22025)
- tacalcitol (Q22024)
- calcipotriol (Q22023)
- dihydrotachysterol (Q22022)
- alfacalcidol (Q22021)
- vitamin D4 metabolic process (Q22020)
- vitamin D4 (Q22019)
- 24,25,26,27-tetranor-9,10-secocholestane steroid (Q22018)
- calcitroic acid (Q22017)
- secondary hyperparathyroidism (Q22016)
- secondary hyperparathyroidism of renal origin (Q22015)
- rare genetic parathyroid disease and phosphocalcic metabolism disorder (Q22014)
- rare genetic bone disease (Q22013)
- rare genetic bone development disorder (Q22012)
- primary bone dysplasia (Q22011)
- primary bone dysplasia with defective bone mineralization (Q22010)
- rare parathyroid disease and phosphocalcic metabolism anomaly (Q22009)
- disorders of vitamin D metabolism (Q22008)
- vitamin D deficiency (Q22007)
- metabolic bone disease (Q22006)
- (23S)-23,25-dihydroxycalciol (Q22005)
- 25-hydroxycholecalciferol-23-hydroxylase activity (Q22004)
- vasoconstriction (Q22003)
- vasoconstrictor agents (Q22002)
- calcium channel agonists (Q22001)
- autoimmune skin disease (Q22000)
- psoriasis (Q21999)
- antipsoriatic (Q21998)
- hyperparathyroidism (Q21997)
- vitamin D 23-hydroxylase activity (Q21996)
- 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity (Q21995)
- calcitriol binding (Q21994)